https://cooleyma.com/ 2026-09-21T17:06:04+00:00 https://cooleyma.com/cookies-policy/ 2026-04-17T21:01:52+00:00 https://cooleyma.com/follow/ 2025-04-18T23:22:25+00:00 https://cooleyma.com/resources/ 2026-03-04T17:14:49+00:00 https://cooleyma.com/cooley-team/ 2026-08-18T13:56:25+00:00 https://cooleyma.com/2026/09/21/spooky-season-merger-agreements-rise-from-the-dead-in-verisk-ruling/ 2026-09-21T17:26:54+00:00 https://cooleyma.com/2026/09/15/doj-announces-historic-250-million-penalty-for-hsr-filing-violations/ 2026-09-15T15:43:31+00:00 https://cooleyma.com/2026/09/08/choosing-your-corporate-home-a-trade-off-guide-for-founder-led-tech-companies/ 2026-09-03T17:59:12+00:00 https://cooleyma.com/2026/09/02/ftc-requiring-divestitures-approves-final-consent-decree-in-ascension-amsurg-deal/ 2026-09-01T23:15:37+00:00 https://cooleyma.com/2026/08/24/ftc-court-win-blocks-henkels-acquisition-of-liquid-nails/ 2026-08-24T15:10:26+00:00 https://cooleyma.com/2026/08/11/court-holds-revlon-duties-dont-apply-to-pbc-in-change-of-control-transaction/ 2026-08-11T19:31:18+00:00 https://cooleyma.com/2026/07/29/cooley-market-talks-the-technology-outlook-h2-2026-and-beyond/ 2026-07-29T19:33:22+00:00 https://cooleyma.com/2026/07/27/ftc-secures-record-12-million-penalty-for-hsr-violation/ 2026-08-24T15:56:21+00:00 https://cooleyma.com/deals/gptzero-to-be-acquired-by-superhuman/ 2026-07-15T19:48:21+00:00 https://cooleyma.com/deals/first-street-acquired-by-msci/ 2026-07-15T19:47:57+00:00 https://cooleyma.com/deals/cred-receives-significant-investment-from-meta/ 2026-07-15T19:47:32+00:00 https://cooleyma.com/deals/fin-to-be-acquired-by-salesforce-for-approximately-3-6-billion/ 2026-07-15T19:46:46+00:00 https://cooleyma.com/deals/cooley-advises-zincfive-on-despac-transaction-with-spark-i-acquisition-corp/ 2026-07-15T19:45:46+00:00 https://cooleyma.com/2026/06/29/navigating-ma-in-todays-exit-market-for-funds/ 2026-06-29T18:31:37+00:00 https://cooleyma.com/deals/avenzo-therapeutics-to-be-acquired-by-rallybio/ 2026-06-02T18:32:21+00:00 https://cooleyma.com/deals/curevo-vaccine-to-be-acquired-by-eli-lilly-for-up-to-1-5-billion/ 2026-06-02T18:31:58+00:00 https://cooleyma.com/deals/vaccine-company-to-be-acquired-by-eli-lilly-for-up-to-1-5-billion/ 2026-06-02T18:31:22+00:00 https://cooleyma.com/deals/engage-bio-acquired-by-eli-lilly-for-up-to-202-million/ 2026-06-02T18:30:34+00:00 https://cooleyma.com/deals/orphai-therapeutics-sale-to-quince-therapeutics/ 2026-06-02T18:30:06+00:00 https://cooleyma.com/deals/iridium-communications-acquires-aireon/ 2026-06-02T18:29:11+00:00 https://cooleyma.com/deals/908-devices-inc-acquires-nirlab-ag/ 2026-06-02T18:28:30+00:00 https://cooleyma.com/deals/bluecore-acquired-by-insider-one/ 2026-06-02T18:27:59+00:00 https://cooleyma.com/deals/avantia-acquired-by-carta/ 2026-06-02T18:26:49+00:00 https://cooleyma.com/deals/openai-forms-new-joint-venture-openai-deployment-company-and-acquires-tomoro/ 2026-06-02T18:26:15+00:00 https://cooleyma.com/deals/brown-advisory-strategic-investment-in-rockcreek/ 2026-06-02T18:24:38+00:00 https://cooleyma.com/deals/core-scientific-acquisition-of-polaris-for-up-to-461-million/ 2026-06-02T18:20:10+00:00 https://cooleyma.com/deals/candid-therapeutics-acquired-by-ucb-for-up-to-2-2-billion/ 2026-06-02T18:18:29+00:00 https://cooleyma.com/2026/05/26/coordinating-hawkeyes-acquisition-financings-and-ipo-at-orbit-speed/ 2026-05-26T18:01:50+00:00 https://cooleyma.com/2026/05/07/sec-exemptive-order-halves-minimum-tender-offer-period-for-negotiated-all-cash-transactions/ 2026-05-07T19:08:31+00:00 https://cooleyma.com/deals/ajax-therapeutics-acquired-by-eli-lilly-for-up-to-2-3-billion/ 2026-04-30T20:34:17+00:00 https://cooleyma.com/deals/fluidstack-joint-venture-to-issue-5-7-billion-in-senior-secured-notes/ 2026-04-30T20:27:35+00:00 https://cooleyma.com/deals/crossbridge-bio-acquired-by-eli-lilly-and-co-for-up-to-300-million/ 2026-04-30T20:25:36+00:00 https://cooleyma.com/deals/press-release-greenspark-and-rematter-combine-to-form-respark/ 2026-04-30T20:24:09+00:00 https://cooleyma.com/deals/neurocrine-acquisition-of-soleno-for-2-9-billion/ 2026-04-30T20:22:12+00:00 https://cooleyma.com/deals/korsana-biosciences-announces-merger-with-cyclerion-therapeutics-concurrent-380-million-private-financing/ 2026-04-30T20:21:15+00:00 https://cooleyma.com/deals/pro-football-focus-sale-of-enterprise-business-to-teamworks/ 2026-04-30T20:19:33+00:00 https://cooleyma.com/deals/kezar-life-sciences-acquired-by-aurinia-pharmaceuticals/ 2026-04-30T20:18:34+00:00 https://cooleyma.com/deals/theguarantors-announces-growth-investment-from-warburg-pincus/ 2026-04-30T20:16:59+00:00 https://cooleyma.com/2026/04/30/cooley-market-talks-ai-and-the-new-capital-dynamic-ipos-ma-and-what-comes-next/ 2026-04-30T18:03:03+00:00 https://cooleyma.com/2026/04/16/yes-your-ceos-ai-prompts-may-be-discoverable-and-can-be-problematic/ 2026-05-04T17:37:21+00:00 https://cooleyma.com/2026/03/30/dual-track-processes-how-to-turbocharge-your-exit-2/ 2026-03-30T18:26:33+00:00 https://cooleyma.com/2026/03/26/delaware-supreme-court-rejects-constitutional-challenges-to-dgcl-safe-harbor-amendments/ 2026-03-26T14:32:38+00:00 https://cooleyma.com/2026/03/11/delaware-supreme-court-reverses-moelis-holding-claims-regarding-stockholder-agreement-are-time-barred/ 2026-03-11T16:44:52+00:00 https://cooleyma.com/deals/candid-therapeutics-announces-merger-with-rallybio-corporation-concurrent-private-financing-of-505-million/ 2026-03-09T18:31:53+00:00 https://cooleyma.com/deals/35pharma-enters-agreement-to-be-acquired-by-gsk/ 2026-03-13T16:48:18+00:00 https://cooleyma.com/deals/iqm-announces-merger-with-real-asset-acquisition-corp-concurrent-pipe-financing/ 2026-03-09T18:30:45+00:00 https://cooleyma.com/deals/sensei-biotherapeutics-announces-acquisition-of-faeth-therapeutics/ 2026-03-09T18:29:44+00:00 https://cooleyma.com/deals/grab-acquires-stash/ 2026-03-09T18:29:09+00:00 https://cooleyma.com/deals/quantum-leap-acquires-veros-technologies/ 2026-03-09T18:28:36+00:00 https://cooleyma.com/deals/mari-acquires-majority-stake-in-bucket-listers/ 2026-03-09T18:28:11+00:00 https://cooleyma.com/deals/spring-healths-acquisition-of-alma/ 2026-03-09T18:27:17+00:00 https://cooleyma.com/deals/clorox-announces-2-25-billion-acquisition-of-gojo-industries-makers-of-purell/ 2026-03-09T18:26:45+00:00 https://cooleyma.com/deals/yelp-announces-acquisition-of-hatch/ 2026-03-09T18:25:53+00:00 https://cooleyma.com/deals/lightning-ai-and-voltage-park-complete-merger/ 2026-03-09T18:24:18+00:00 https://cooleyma.com/deals/gsk-agrees-to-acquire-rapt-therapeutics-for-2-2-billion/ 2026-03-09T18:23:56+00:00 https://cooleyma.com/deals/observe-announces-acquisition-by-snowflake/ 2026-03-09T18:23:32+00:00 https://cooleyma.com/deals/dynavax-to-be-acquired-by-sanofi-for-2-2-billion/ 2026-03-09T18:22:09+00:00 https://cooleyma.com/deals/qualified-to-be-acquired-by-salesforce/ 2026-03-09T18:20:43+00:00 https://cooleyma.com/deals/confluent-to-be-acquired-by-ibm/ 2026-03-09T18:20:20+00:00 https://cooleyma.com/deals/cidara-therapeutics-to-be-acquired-by-merck/ 2026-03-09T18:19:55+00:00 https://cooleyma.com/deals/cooley-advises-prizepicks-on-sale-to-allwyn-for-up-to-4-15-billion/ 2026-03-09T18:19:21+00:00 https://cooleyma.com/deals/cooley-advises-investor-syndicate-on-2-25-billion-acquisition-of-histosonics/ 2026-03-09T18:18:45+00:00 https://cooleyma.com/deals/vicebio-to-be-acquired-by-sanofi-for-1-6-billion/ 2026-03-09T18:18:09+00:00 https://cooleyma.com/deals/play-ai-acquired-by-meta/ 2026-03-09T18:16:44+00:00 https://cooleyma.com/deals/capstan-therapeutics-announces-up-to-2-1-billion-acquisition-by-abbvie/ 2026-03-09T18:16:09+00:00 https://cooleyma.com/deals/siteone-therapeutics-to-be-acquired-by-eli-lilly-for-up-to-1-billion/ 2026-03-09T18:15:14+00:00 https://cooleyma.com/deals/cooley-advises-io-products-on-6-5-billion-acquisition-by-openai/ 2026-03-09T18:14:05+00:00 https://cooleyma.com/deals/boston-celtics-announce-6-1-billion-sale-to-group-led-by-william-chisholm/ 2026-03-09T18:13:31+00:00 https://cooleyma.com/deals/esobiotec-announces-up-to-1-billion-acquisition-by-astrazeneca/ 2026-03-09T18:12:35+00:00 https://cooleyma.com/deals/poppi-announces-1-95-billion-sale-to-pepsico/ 2026-03-09T18:11:56+00:00 https://cooleyma.com/deals/araris-biotechs-up-to-1-14-billion-acquisition-by-taiho-pharmaceutical/ 2026-03-09T18:11:23+00:00 https://cooleyma.com/deals/datastax-announces-acquisition-by-ibm/ 2026-03-09T18:10:17+00:00 https://cooleyma.com/deals/alani-nus-1-8-billion-sale-to-celsius/ 2026-03-09T18:10:12+00:00 https://cooleyma.com/deals/lantheus-to-acquire-evergreen-theragnostics-for-up-to-1-billion/ 2026-03-09T18:10:01+00:00 https://cooleyma.com/deals/poseida-therapeutics-announces-agreement-to-be-acquired-by-roche-for-up-to-1-5-billion/ 2026-03-09T18:09:56+00:00 https://cooleyma.com/deals/avid-bioservices-announces-1-1-billion-acquisition-by-gho-capital-partners-and-ampersand-capital-partners/ 2026-03-09T18:09:47+00:00 https://cooleyma.com/deals/longboard-pharmaceuticals-announces-2-6-billion-sale-to-lundbeck/ 2026-03-09T18:09:33+00:00 https://cooleyma.com/2026/03/06/the-private-equity-developments-that-defined-2025/ 2026-03-06T21:48:19+00:00 https://cooleyma.com/2026/02/26/2026-antitrust-outlook-learnings-from-the-first-year-of-america-first-enforcement/ 2026-02-26T20:47:15+00:00 https://cooleyma.com/2026/02/25/comparative-playbook-navigating-conflicts-in-delaware-and-nevada/ 2026-05-13T20:41:51+00:00 https://cooleyma.com/2026/02/23/uk-merger-control-in-2026-what-to-expect/ 2026-02-23T20:54:28+00:00 https://cooleyma.com/2026/02/10/cooleys-2026-year-ahead-for-life-sciences-ma-competition-and-creativity-in-a-dynamic-environment/ 2026-02-11T20:15:48+00:00 https://cooleyma.com/2026/02/02/cooleys-2025-tech-ma-year-in-review-tech-ma-revival-big-deals-keep-on-turnin/ 2026-02-02T22:46:39+00:00 https://cooleyma.com/2026/01/29/cooleys-2025-activism-retrospective/ 2026-01-29T21:09:32+00:00 https://cooleyma.com/2026/01/21/ftc-issues-2026-hsr-filing-thresholds-fee-adjustments-and-interlocking-directorate-updates/ 2026-01-21T20:22:27+00:00 https://cooleyma.com/2025/12/12/so-you-think-you-can-deal-jump/ 2026-02-17T20:46:04+00:00 https://cooleyma.com/2025/11/04/sports-investing-101/ 2025-11-04T21:03:27+00:00 https://cooleyma.com/2025/10/15/activism-in-2025-and-beyond-universal-proxy-litigation-leverage-and-a-new-playbook-for-preparedness/ 2025-10-15T17:12:25+00:00 https://cooleyma.com/2025/10/02/us-government-shutdown-impact-on-antitrust-enforcement-expect-delays-in-merger-review-investigations-litigation/ 2025-10-02T01:37:10+00:00 https://cooleyma.com/2025/06/24/reincorporation-considerations-for-late-stage-private-and-pre-ipo-companies/ 2025-06-24T19:09:55+00:00 https://cooleyma.com/2025/05/20/cfius-non-notified-transaction-enforcement-cooleys-five-year-lookback/ 2025-05-20T18:42:32+00:00 https://cooleyma.com/2025/04/10/shifting-sands-recent-developments-in-uk-merger-control/ 2025-04-10T18:05:57+00:00 https://cooleyma.com/2025/03/27/delaware-enacts-amendments-to-provide-safe-harbors-for-conflicted-transactions/ 2025-04-02T22:33:09+00:00 https://cooleyma.com/2025/03/12/new-cdis-related-to-ma/ 2025-03-12T14:59:07+00:00 https://cooleyma.com/2025/02/27/ofsi-steps-up-the-future-of-uk-sanctions-enforcement/ 2025-02-27T16:29:48+00:00 https://cooleyma.com/2025/02/20/new-delaware-bill-would-offer-safe-harbor-for-conflicted-transactions-will-it-convince-companies-to-stay-put-in-delaware/ 2025-02-20T17:10:21+00:00 https://cooleyma.com/2025/02/14/the-private-equity-developments-that-defined-2024/ 2025-02-14T17:38:45+00:00 https://cooleyma.com/2025/02/11/antitrust-in-2025-shifting-sands-and-what-to-expect/ 2025-02-11T16:29:47+00:00 https://cooleyma.com/2025/02/07/delaware-supreme-court-reverses-chancery-court-holds-business-judgment-review-applicable-to-tripadvisors-decision-to-reincorporate-in-nevada/ 2025-02-07T18:40:23+00:00 https://cooleyma.com/2025/02/03/cooleys-2024-tech-ma-year-in-reviewwere-so-back-its-so-over/ 2025-03-27T22:54:27+00:00 https://cooleyma.com/2025/01/30/cooleys-2024-activism-year-in-review-activists-ascendent/ 2025-02-11T15:39:51+00:00 https://cooleyma.com/2025/01/28/new-hart-scott-rodino-act-filing-thresholds-filing-fees-and-interlocking-directorate-thresholds-announced-2/ 2025-01-28T16:17:15+00:00 https://cooleyma.com/2025/01/22/cooleys-2024-life-sciences-ma-year-in-review-ma-slims-down-in-2024-but-will-appetites-grow-in-2025/ 2025-01-24T17:08:12+00:00 https://cooleyma.com/2024/12/13/navigating-the-new-european-commissions-ma-landscape-what-in-house-counsel-need-to-know/ 2024-12-13T17:49:24+00:00 https://cooleyma.com/2024/10/24/learning-old-lessons-from-recent-life-sciences-earnout-disputes-above-all-else-words-matter/ 2024-10-24T20:11:49+00:00 https://cooleyma.com/2024/10/22/key-considerations-as-ftc-doj-significantly-change-hsr-premerger-notification-requirements/ 2024-10-22T18:43:17+00:00 https://cooleyma.com/2024/09/25/as-cfius-announces-significant-penalties-companies-and-investors-confront-a-shift-in-cfius-filing-cost-benefit-dynamics/ 2024-09-25T13:15:00+00:00 https://cooleyma.com/2024/09/19/not-the-show-they-wanted-doj-hits-venue-services-group-with-3-5-million-hsr-gun-jumping-penalty/ 2024-09-19T13:00:00+00:00 https://cooleyma.com/deals/gebbs-healthcare-solutions-announces-sale-to-eqt-private-capital-asia/ 2024-09-18T21:50:41+00:00 https://cooleyma.com/deals/confluent-acquires-warpstream/ 2024-09-18T21:50:11+00:00 https://cooleyma.com/deals/personalis-announces-expanded-collaboration-with-tempus-ai/ 2024-09-18T21:49:23+00:00 https://cooleyma.com/deals/transact-campus-announces-1-6-billion-sale-to-roper-technologies/ 2024-09-18T21:48:40+00:00 https://cooleyma.com/deals/cents-announces-40-million-series-b-financing-and-acquisition-of-laundroworks/ 2024-09-18T21:48:02+00:00 https://cooleyma.com/deals/petiq-announces-definitive-merger-agreement-with-bansk-group-valued-at-approximately-1-5-billion/ 2024-09-18T21:47:13+00:00 https://cooleyma.com/deals/boldend-to-sell-to-sixgen/ 2024-09-18T21:46:36+00:00 https://cooleyma.com/deals/blacksignal-technologies-announces-200-million-sale-to-parsons/ 2024-09-18T21:46:03+00:00 https://cooleyma.com/deals/nerio-therapeutics-sells-to-boehringer-ingelheim-for-up-to-1-3-billion/ 2024-09-18T21:45:23+00:00 https://cooleyma.com/deals/cepton-signs-definitive-agreement-to-sell-to-koito/ 2024-09-18T21:44:48+00:00 https://cooleyma.com/deals/summer-fridays-announces-strategic-investment-from-tsg-consumer-partners/ 2024-09-18T21:44:14+00:00 https://cooleyma.com/deals/mott-corporation-agrees-to-sell-to-idex-corporation-for-1-billion/ 2024-09-18T21:43:19+00:00 https://cooleyma.com/deals/radionetics-oncology-announces-strategic-agreement-with-eli-lilly/ 2024-09-18T21:41:50+00:00 https://cooleyma.com/deals/carejourney-acquired-by-arcadia/ 2024-09-18T21:41:11+00:00 https://cooleyma.com/deals/rooam-to-be-acquired-by-american-express/ 2024-09-18T21:40:40+00:00 https://cooleyma.com/deals/perceptive-advisors-enters-into-definitive-merger-agreement-with-vapotherm/ 2024-09-18T21:39:24+00:00 https://cooleyma.com/deals/adarga-acquires-j2x-solutions/ 2024-09-18T21:38:04+00:00 https://cooleyma.com/2024/09/16/13-top-considerations-for-tackling-a-merger-of-equals-transaction-like-a-mastermind/ 2026-04-06T19:52:42+00:00 https://cooleyma.com/2024/07/16/will-a-bump-up-exclusion-bar-coverage-of-an-ma-settlement-it-depends/ 2024-07-16T12:30:00+00:00 https://cooleyma.com/2024/07/10/4-tips-for-drafting-earnouts-to-avoid-disputes/ 2024-07-10T15:24:54+00:00 https://cooleyma.com/deals/lacework-to-be-acquired-by-fortinet/ 2024-06-18T20:20:27+00:00 https://cooleyma.com/deals/tenable-to-acquire-eureka-security/ 2024-06-18T18:05:02+00:00 https://cooleyma.com/deals/auditboard-to-be-acquired-by-hg-for-more-than-3-billion/ 2024-06-18T17:53:34+00:00 https://cooleyma.com/2024/06/12/recent-release-of-updated-procedures-for-section-355-private-letter-rulings/ 2024-06-12T15:03:45+00:00 https://cooleyma.com/2024/06/10/beyond-borders-a-guide-for-navigating-the-european-regulatory-landscape/ 2024-06-10T12:00:00+00:00 https://cooleyma.com/deals/squarespace-to-go-private-in-6-9-billion-transaction-with-permira/ 2024-05-28T19:52:03+00:00 https://cooleyma.com/deals/ags-announces-definitive-agreement-to-be-acquired-by-brightstar-capital-partners-for-1-1-billion/ 2024-06-18T04:32:52+00:00 https://cooleyma.com/deals/wso2-to-be-acquired-by-eqt/ 2024-05-28T19:48:14+00:00 https://cooleyma.com/deals/freshworks-agrees-to-acquire-device42/ 2024-05-28T19:46:01+00:00 https://cooleyma.com/deals/nuvalence-announces-acquisition-by-ey/ 2024-05-28T19:44:13+00:00 https://cooleyma.com/deals/cidara-therapeutics-announces-concurrent-reacquisition-of-ip-rights-to-cd388-240-million-pipe-financing/ 2024-06-18T04:16:39+00:00 https://cooleyma.com/deals/tenet-medicines-to-be-acquired-by-eliem-therapeutics/ 2024-05-28T19:29:42+00:00 https://cooleyma.com/deals/automattic-acquires-beeper/ 2024-05-28T19:28:15+00:00 https://cooleyma.com/deals/hootsuite-to-acquire-talkwalker/ 2024-06-18T04:31:28+00:00 https://cooleyma.com/deals/profoundbio-announces-1-8-billion-acquisition-by-genmab/ 2024-05-24T19:37:02+00:00 https://cooleyma.com/2024/05/23/representation-and-warranty-insurance-for-ma-deals-cooling-market-and-emerging-trends/ 2024-05-23T13:50:06+00:00 https://cooleyma.com/2024/05/01/irs-publishes-proposed-regulations-on-stock-buyback-excise-tax/ 2024-05-01T13:30:00+00:00 https://cooleyma.com/2024/04/17/delaware-supreme-court-applies-mfw-framework-to-other-conflicted-transactions/ 2024-04-17T13:00:00+00:00 https://cooleyma.com/2024/04/05/delaware-double-whammy-casts-doubt-on-ma-practices/ 2024-04-05T17:53:15+00:00 https://cooleyma.com/deals/landos-biopharma-to-be-acquired-by-abbvie/ 2024-03-29T01:50:34+00:00 https://cooleyma.com/deals/nuvation-bio-to-acquire-anheart-therapeutics/ 2024-03-29T01:48:30+00:00 https://cooleyma.com/deals/rubicon-technology-partners-announces-investment-in-ascend-analytics/ 2024-03-29T01:46:29+00:00 https://cooleyma.com/deals/sazerac-agrees-to-acquire-buzzballz/ 2024-03-29T01:44:44+00:00 https://cooleyma.com/deals/amolyt-pharma-agrees-to-be-acquired-by-astrazeneca-in-up-to-1-05-billion-cross-border-transaction/ 2024-03-29T01:42:26+00:00 https://cooleyma.com/deals/jmi-equity-sells-incident-iq-to-cove-hill-partners/ 2024-03-29T01:40:19+00:00 https://cooleyma.com/deals/hiredscore-to-be-acquired-by-workday/ 2024-03-29T01:38:47+00:00 https://cooleyma.com/deals/jackpocket-reaches-agreement-to-be-acquired-by-draftkings-for-750-million/ 2024-02-20T18:56:05+00:00 https://cooleyma.com/deals/everbridge-enters-into-definitive-agreement-to-be-acquired-by-thoma-bravo-for-1-5-billion/ 2024-02-16T01:21:05+00:00 https://cooleyma.com/deals/tectonic-therapeutic-announces-merger-with-avrobio-130-7-million-private-financing-commitments/ 2024-02-16T00:20:59+00:00 https://cooleyma.com/deals/sevenrooms-acquires-heypluto/ 2024-02-16T00:19:05+00:00 https://cooleyma.com/deals/payapps-to-be-acquired-by-autodesk/ 2024-02-16T00:17:29+00:00 https://cooleyma.com/2024/02/08/new-hart-scott-rodino-act-filing-thresholds-filing-fees-and-interlocking-directorate-thresholds-announced/ 2024-02-08T14:30:00+00:00 https://cooleyma.com/2024/02/01/cooleys-2023-tech-ma-year-in-review-an-ai-generated-glass-half-full/ 2024-02-01T18:15:38+00:00 https://cooleyma.com/deals/yieldstreet-completes-acquisition-of-cadre/ 2024-01-31T19:42:44+00:00 https://cooleyma.com/2024/01/30/cooleys-2023-activism-year-in-review-wolfpacks-at-the-gate/ 2024-01-30T17:30:52+00:00 https://cooleyma.com/2024/01/25/cooleys-2023-cross-border-ma-year-in-review-navigating-choppy-waters-into-a-more-buoyant-2024/ 2024-01-26T22:53:47+00:00 https://cooleyma.com/2024/01/23/cooleys-2023-life-sciences-ma-year-in-review-potent-mix-of-creativity-and-resilience-spurs-activity-heading-into-2024/ 2024-02-12T20:40:36+00:00 https://cooleyma.com/deals/psi-group-plans-nasdaq-listing-through-merger-with-aib-acquisition-corporation/ 2024-01-23T02:49:36+00:00 https://cooleyma.com/deals/madcap-software-acquires-xyleme/ 2024-01-23T02:47:36+00:00 https://cooleyma.com/deals/cooley-advises-lantheus-on-concurrent-pipe-investment-partnering-transaction-asset-sale-with-perspective-therapeutics/ 2024-01-23T02:39:53+00:00 https://cooleyma.com/deals/gracell-biotechnologies-to-be-acquired-by-astrazeneca-for-up-to-approximately-1-2-billion/ 2024-01-22T21:54:25+00:00 https://cooleyma.com/deals/rayzebio-signs-approximately-4-1-billion-acquisition-agreement-with-bristol-myers-squibb/ 2024-01-22T21:44:07+00:00 https://cooleyma.com/deals/healthtrio-combines-with-mpulse-and-decision-point-healthcare-solutions/ 2024-01-22T21:42:48+00:00 https://cooleyma.com/2024/01/10/new-year-new-merger-guidelines-what-dealmakers-need-to-know/ 2024-01-10T22:21:25+00:00 https://cooleyma.com/deals/carmot-therapeutics-enters-definitive-merger-agreement-with-roche/ 2023-12-05T18:16:40+00:00 https://cooleyma.com/deals/propella-therapeutics-enters-merger-agreement-with-astellas-pharma/ 2023-11-29T01:34:28+00:00 https://cooleyma.com/deals/calltower-receives-investment-from-bv-investment-partners/ 2023-11-28T23:07:41+00:00 https://cooleyma.com/deals/li-cor-environmental-acquires-apollo-scitechs-assets/ 2023-11-28T22:59:05+00:00 https://cooleyma.com/2023/11/27/corp-fin-issues-new-cdis-regarding-the-proxy-rules/ 2023-11-27T15:38:01+00:00 https://cooleyma.com/2023/11/20/navigating-compensation-issues-in-ma-deals-in-a-volatile-market/ 2023-11-20T18:10:55+00:00 https://cooleyma.com/2023/11/15/the-state-of-delaware/ 2023-11-15T16:20:00+00:00 https://cooleyma.com/deals/zillow-agrees-to-acquire-follow-up-boss/ 2023-11-14T20:09:36+00:00 https://cooleyma.com/deals/affable-technologies-sells-affable-ai-to-bazaarvoice/ 2023-11-01T14:52:30+00:00 https://cooleyma.com/deals/nuvolo-agrees-to-sell-to-trane-technologies/ 2023-11-01T14:50:53+00:00 https://cooleyma.com/deals/contentsquare-agrees-to-acquire-heap/ 2023-11-01T14:43:10+00:00 https://cooleyma.com/deals/tenable-agrees-to-acquire-ermetic/ 2023-11-01T06:26:52+00:00 https://cooleyma.com/deals/dhc-acquisition-corp-combines-with-brand-engagement-network/ 2023-11-01T06:06:00+00:00 https://cooleyma.com/deals/laborie-medical-technologies-agrees-to-acquire-urotronic/ 2023-11-01T06:04:33+00:00 https://cooleyma.com/deals/battery-ventures-acquires-grammatechs-software-products/ 2023-11-01T05:50:46+00:00 https://cooleyma.com/deals/trisalus-life-sciences-completes-merger-with-medtech-acquisition-corporation/ 2023-11-01T05:41:11+00:00 https://cooleyma.com/deals/tentarix-biotherapeutics-announces-three-collaborations-plus-acquisition-options-with-gilead-sciences/ 2023-11-01T05:39:34+00:00 https://cooleyma.com/deals/definitive-healthcare-acquires-populi/ 2023-11-01T05:36:09+00:00 https://cooleyma.com/deals/senti-biosciences-sells-certain-assets-to-celadon-partners/ 2023-11-01T05:34:17+00:00 https://cooleyma.com/deals/vietnamese-sunergy-cell-company-limited-combines-with-blue-world-acquisition-company/ 2023-11-01T05:32:58+00:00 https://cooleyma.com/deals/sprout-social-acquires-tagger-media/ 2023-11-01T05:31:31+00:00 https://cooleyma.com/deals/bridge-to-life-sells-certain-assets-to-transmedics/ 2023-11-01T05:29:58+00:00 https://cooleyma.com/deals/medigo-announces-acquisition-by-caredx/ 2023-11-01T05:20:03+00:00 https://cooleyma.com/deals/midwestern-electric-acquires-kuharchik-construction-and-wyoming-electric-signals/ 2023-11-01T01:16:01+00:00 https://cooleyma.com/deals/versanis-bios-announces-acquisition-by-eli-lilly/ 2023-11-01T01:13:10+00:00 https://cooleyma.com/deals/travere-sells-bile-acid-product-portfolio-to-mirum/ 2023-11-01T01:01:29+00:00 https://cooleyma.com/deals/cybergrx-combines-with-processunity/ 2023-11-01T00:58:35+00:00 https://cooleyma.com/deals/liminal-biosciences-to-be-acquired-by-structured-alpha/ 2023-11-01T00:45:27+00:00 https://cooleyma.com/deals/digitalocean-acquires-paperspace-for-111-million/ 2023-11-01T00:41:49+00:00 https://cooleyma.com/deals/morphimmune-announces-merger-with-immunome-and-125-million-private-investment/ 2023-11-01T00:38:30+00:00 https://cooleyma.com/deals/thoughtspot-acquires-mode-analytics/ 2023-11-01T00:35:54+00:00 https://cooleyma.com/deals/aeglea-biotherapeutics-announces-acquisition-of-spyre-therapeutics-and-concurrent-pipe-investment/ 2023-11-01T00:30:01+00:00 https://cooleyma.com/deals/tourmaline-bio-agrees-to-merge-with-talaris-therapeutics/ 2023-11-01T00:26:02+00:00 https://cooleyma.com/deals/thirty-madison-acquires-assets-from-the-pill-club-in-section-363-sale/ 2023-11-01T00:24:22+00:00 https://cooleyma.com/deals/cero-therapeutics-merges-with-phoenix-biotech-acquisition-corp/ 2023-11-01T00:13:40+00:00 https://cooleyma.com/deals/cooley-advises-on-mindmeds-successful-proxy-contest/ 2023-11-01T00:12:17+00:00 https://cooleyma.com/deals/snyk-acquires-enso-security/ 2023-11-01T00:06:18+00:00 https://cooleyma.com/deals/veritone-acquires-broadbean/ 2023-11-01T00:04:05+00:00 https://cooleyma.com/deals/vectivbio-to-be-acquired-by-ironwood/ 2023-11-01T00:02:17+00:00 https://cooleyma.com/deals/toluna-acquires-metrixlab/ 2023-10-31T23:57:15+00:00 https://cooleyma.com/deals/absolute-software-announces-870-million-acquisition-by-crosspoint-capital/ 2023-10-31T23:54:07+00:00 https://cooleyma.com/deals/zion-pharma-announces-sale-of-lead-program-to-roche/ 2023-10-31T23:52:23+00:00 https://cooleyma.com/deals/nkgen-biotech-announces-merger-with-graf-acquisition-corp-iv/ 2023-10-31T23:49:43+00:00 https://cooleyma.com/deals/bitdeer-announces-merger-with-blue-safari/ 2023-10-31T23:39:09+00:00 https://cooleyma.com/deals/uber-sells-50-stake-in-careems-super-app-to-e/ 2023-10-31T23:37:19+00:00 https://cooleyma.com/deals/bavarian-nordic-acquires-emergent-biosolutions-travel-vaccines-portfolio/ 2023-10-31T23:21:05+00:00 https://cooleyma.com/deals/justin-bieber-to-sell-music-rights-to-hipgnosis-songs-for-200-million/ 2023-10-31T22:55:17+00:00 https://cooleyma.com/deals/world-view-to-list-in-350-million-spac-deal/ 2023-10-31T19:41:21+00:00 https://cooleyma.com/deals/amryt-pharma-to-sell-to-chiesi-farmaceutici-in-1-48-billion-cross-border-transaction/ 2023-10-31T19:03:51+00:00 https://cooleyma.com/2023/10/23/recorded-event-a-discussion-on-the-ma-outlook-for-2024recorded-event/ 2023-10-23T14:18:03+00:00 https://cooleyma.com/2023/10/13/event-recording-capital-markets-and-the-resurgence-of-private-equity/ 2023-10-13T13:57:11+00:00 https://cooleyma.com/2023/10/04/apples-oranges-and-lemonade-pursuing-multiple-strategic-alternatives-in-the-public-company-boardroom/ 2023-10-04T15:31:08+00:00 https://cooleyma.com/2023/09/18/cooley-publishes-updated-cfius-overview-page/ 2023-09-27T17:04:16+00:00 https://cooleyma.com/2023/09/13/dojs-top-antitrust-official-turns-spotlight-on-broadened-scope-of-bank-merger-enforcement/ 2023-09-13T16:59:01+00:00 https://cooleyma.com/2023/08/10/court-of-justice-sets-lightning-rod-for-eu-foreign-direct-investment-screening/ 2023-09-27T17:14:42+00:00 https://cooleyma.com/2023/08/01/eus-foreign-subsidies-check-for-ma-deals-goes-live/ 2023-09-27T17:12:31+00:00 https://cooleyma.com/2023/07/26/draft-revised-merger-guidelines-foreshadow-more-aggressive-antitrust-enforcement/ 2023-07-26T18:01:59+00:00 https://cooleyma.com/2023/07/20/keeping-up-with-ma-case-law-spotlight-on-recent-delaware-decisions/ 2023-09-12T01:06:39+00:00 https://cooleyma.com/2023/07/05/ftc-proposes-sweeping-changes-to-hsr-rules-that-could-substantially-increase-burden-time-to-prepare-filings/ 2023-09-27T17:13:05+00:00 https://cooleyma.com/2023/06/01/assessing-overlapping-boards-after-doj-crackdown/ 2023-09-27T17:13:36+00:00 https://cooleyma.com/2023/04/17/europes-top-court-on-merger-review-no-deals-are-off-the-table/ 2023-09-27T17:19:54+00:00 https://cooleyma.com/2023/03/22/life-sciences-reverse-mergers-go-global-is-it-the-path-for-your-company/ 2023-09-27T17:21:03+00:00 https://cooleyma.com/2023/03/21/corp-fin-posts-update-to-tender-offer-cdis/ 2023-09-27T17:21:42+00:00 https://cooleyma.com/deals/cincor-pharma-to-sell-to-astrazeneca-for-approximately-1-8-billion/ 2023-02-08T18:39:00+00:00 https://cooleyma.com/2023/02/07/cross-border-ma-10-key-trends-from-across-the-pond/ 2023-09-27T17:22:46+00:00 https://cooleyma.com/2023/01/27/new-hart-scott-rodino-act-thresholds-and-filing-fees-announced/ 2023-09-27T17:23:04+00:00 https://cooleyma.com/2023/01/25/cooleys-2022-tech-ma-year-in-review/ 2023-09-27T17:31:04+00:00 https://cooleyma.com/2023/01/25/cooleys-2022-life-sciences-ma-year-in-review/ 2023-09-27T17:29:39+00:00 https://cooleyma.com/2023/01/19/interim-guidance-on-stock-buyback-excise-tax-confirms-broad-application-to-ma-and-capital-market-transactions/ 2023-09-27T17:32:10+00:00 https://cooleyma.com/2023/01/09/highlights-from-the-2022-berkeley-fall-forum-on-corporate-governance/ 2023-09-27T17:33:01+00:00 https://cooleyma.com/2023/01/04/hsr-filing-fees-increase-substantially-for-large-transactions-boost-ftc-and-doj-antitrust-enforcement-funding/ 2023-09-27T17:33:38+00:00 https://cooleyma.com/deals/tmunity-therapeutics-to-sell-to-kite/ 2023-01-03T15:51:48+00:00 https://cooleyma.com/deals/horizon-therapeutics-to-be-acquired-by-amgen-for-approximately-28-billion/ 2022-12-19T17:18:29+00:00 https://cooleyma.com/deals/apollo-endosurgery-to-be-acquired-by-boston-scientific/ 2022-12-19T17:15:33+00:00 https://cooleyma.com/deals/neogene-therapeutics-to-sell-to-astrazeneca/ 2022-12-19T17:12:32+00:00 https://cooleyma.com/deals/oyster-point-pharma-to-be-acquired-by-viatris/ 2022-11-14T22:05:37+00:00 https://cooleyma.com/deals/ritchie-bros-to-acquire-iaa-in-7-3-billion-cross-border-stock-and-cash-transaction/ 2022-11-14T22:02:31+00:00 https://cooleyma.com/deals/oculis-and-european-biotech-acquisition-corp-announce-business-combination-agreement/ 2022-11-14T21:58:56+00:00